General Information of the Compound
| Compound ID |
CP0179389
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3aS,6R,6aS,9aR,9bR)-6-ethyl-1-(1,3-thiazol-2-ylmethyl)-3,3a,4,6,6a,7,8,9,9a,9b-decahydro-2H-benzo[de]quinolin-5-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H26N2OS
|
||||||||||||||||||
| Molecular Weight |
318.486
|
||||||||||||||||||
| Canonical SMILES |
CC[C@@H]1[C@H]2CCC[C@@H]3[C@@H]2[C@@H](CCN3Cc2nccs2)CC1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H26N2OS/c1-2-13-14-4-3-5-15-18(14)12(10-16(13)21)6-8-20(15)11-17-19-7-9-22-17/h7,9,12-15,18H,2-6,8,10-11H2,1H3/t12-,13+,14+,15+,18+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
SRNPPJMAFPXHFT-BHDXSGHGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor